Oaktree Acquisition Corp. III Life Sciences
OACCU- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002029769
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $9.24M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Oaktree Acquisition Corp. III Life Sciences changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 0 | 19 | +19 |
| Shares | 0 | 8.61M | +8.61M |
| Value | $0 | $87.3M | +$87.3M |
New holders (19)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 1,700,000 | $17.3M | 0.04% |
| Millennium Management LLC | 952,422 | $9.65M | 0.01% |
| Driehaus Capital Management LLC | 900,000 | $9.11M | 0.08% |
| Schonfeld Strategic Advisors LLC | 840,828 | $8.52M | 0.05% |
| Linden Advisors LP | 600,000 | $6.09M | 0.05% |
| Moore Capital Management, LP | 525,000 | $5.33M | 0.10% |
| ADAR1 Capital Management, LLC | 500,000 | $5.07M | 1.04% |
| LMR Partners LLP | 475,000 | $4.81M | 0.08% |
| Hudson Bay Capital Management LP | 450,000 | $4.57M | 0.03% |
| Periscope Capital Inc. | 450,000 | $4.56M | 3.23% |
| Ghisallo Capital Management LLC | 450,000 | $4.56M | 0.27% |
| Affinity Asset Advisors, LLC | 250,000 | $2.54M | 0.40% |
| Whitebox Advisors LLC | 250,000 | $2.53M | 0.09% |
| Picton Mahoney Asset Management | 75,000 | $760.0K | 0.03% |
| Kepos Capital LP | 70,000 | $709.0K | 0.61% |
| Citigroup Inc | 50,900 | $515.6K | 0.00% |
| Athos Capital Ltd | 50,000 | $507.0K | 0.24% |
| Rangeley Capital, LLC | 10,000 | $101.3K | 0.10% |
| UBS Group AG | 9,483 | $95.9K | 0.00% |
Sold out (0)
Institutions that held Oaktree Acquisition Corp. III Life Sciences at the end of Q3 2024 and filed for Q4 2024 without it.
None.